Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
Show more...
CEO
Ms. Caroline J. Loew Ph.D.
Karyawan
116
Negara
Irlandia
Pencatatan
0 Comments
Bagikan pendapatmu
FAQ
Apa simbol saham Mural Oncology?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa NASDAQ, saham Mural Oncology diperdagangkan dengan simbol MURA V.
Berapa pendapatan Mural Oncology tahun lalu?▼
Pendapatan Mural Oncology tahun lalu berjumlah 0 USD.
Berapa pendapatan bersih Mural Oncology tahun lalu?▼
Pendapatan bersih MURA V untuk tahun lalu adalah -128,51M USD.
Berapa jumlah karyawan Mural Oncology?▼
Per September 04, 2026, perusahaan memiliki 116 karyawan.
Mural Oncology berada di sektor apa?▼
Mural Oncology beroperasi di sektor Kesehatan & Kebugaran.
Kapan Mural Oncology menyelesaikan split saham?▼
Mural Oncology belum melakukan split saham baru-baru ini.
Di mana kantor pusat Mural Oncology?▼
Kantor pusat Mural Oncology berlokasi di Dublin, Irlandia.